Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Moldovan

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|May 29, 2019
Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRAS<sup>G13D</sup> mutationTheodosia Charitou, Sriganesh Srihari, Miriam A Lynn, et al.
BMC Research Notes|October 11, 2011
Strengthening organizational performance through accreditation research-a framework for twelve interrelated studies: the ACCREDIT project study protocolJeffrey Braithwaite, Johanna Westbrook, Brian Johnston, et al.
Nature Genetics|September 15, 2009
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapyVijayaprakash Suppiah, Max Moldovan, Golo Ahlenstiel, et al.
Scientific Reports|February 3, 2018
Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasionHeather K Armstrong, Joanna L Gillis, Ian R D Johnson, et al.
Elife|August 12, 2021
A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growthJoanna L Gillis, Josephine A Hinneh, Natalie K Ryan, et al.
Plos One|April 15, 2016
Serum 25-Hydroxyvitamin D Status and Longitudinal Changes in Weight and Waist Circumference: Influence of Genetic Predisposition to AdipositySofus C Larsen, Lars Ängquist, Max Moldovan, et al.
Elife|July 21, 2020
Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosisZeyad D Nassar, Chui Yan Mah, Jonas Dehairs, et al.
Cancer Research|August 7, 2021
Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid CompositionLisa M Butler, Chui Yan Mah, Jelle Machiels, et al.
Cell Reports. Medicine|January 14, 2022
Deletions in <i>VANGL1</i> are a risk factor for antibody-mediated kidney diseaseSimon H Jiang, Sevcan Mercan, Ilenia Papa, et al.
Circulation|May 14, 2017
Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization AnalysisCaroline E Dale, Ghazaleh Fatemifar, Tom M Palmer, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|May 29, 2019
Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRAS<sup>G13D</sup> mutationTheodosia Charitou, Sriganesh Srihari, Miriam A Lynn, et al.
BMC Research Notes|October 11, 2011
Strengthening organizational performance through accreditation research-a framework for twelve interrelated studies: the ACCREDIT project study protocolJeffrey Braithwaite, Johanna Westbrook, Brian Johnston, et al.
Nature Genetics|September 15, 2009
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapyVijayaprakash Suppiah, Max Moldovan, Golo Ahlenstiel, et al.
Scientific Reports|February 3, 2018
Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasionHeather K Armstrong, Joanna L Gillis, Ian R D Johnson, et al.
Elife|August 12, 2021
A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growthJoanna L Gillis, Josephine A Hinneh, Natalie K Ryan, et al.
Plos One|April 15, 2016
Serum 25-Hydroxyvitamin D Status and Longitudinal Changes in Weight and Waist Circumference: Influence of Genetic Predisposition to AdipositySofus C Larsen, Lars Ängquist, Max Moldovan, et al.
Elife|July 21, 2020
Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosisZeyad D Nassar, Chui Yan Mah, Jonas Dehairs, et al.
Cancer Research|August 7, 2021
Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid CompositionLisa M Butler, Chui Yan Mah, Jelle Machiels, et al.
Cell Reports. Medicine|January 14, 2022
Deletions in <i>VANGL1</i> are a risk factor for antibody-mediated kidney diseaseSimon H Jiang, Sevcan Mercan, Ilenia Papa, et al.
Circulation|May 14, 2017
Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization AnalysisCaroline E Dale, Ghazaleh Fatemifar, Tom M Palmer, et al.
Pageof 5